FibroBiologics FBLG
NASDAQ FBLG
$1.00 +0.07 (+7.78%)
At close: Nov 11, 2026 · 4:00 PM EST

FibroBiologics (FBLG) EPS (Basic) (2023 - 2026)

Updated

FibroBiologics' EPS (Basic) came in at -$0.66 for Q2 2026, compared with -$2.41 a year earlier.

Analysis

FibroBiologics (FBLG) EPS (Basic) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, FibroBiologics reported EPS (Basic) of -$2.89; for FY2025, it was -$8.35.

  • Going back by year, EPS (Basic) was -$6.79 in FY2024, -$13.50 in FY2023 and -$3.63 in FY2022.
  • The Q2 2026 figure represents the highest quarterly EPS (Basic) since Q3 2024.
  • Business Quant data shows FBLG's EPS (Basic) at -$1.33 (Q1 2026), -$1.45 (Q4 2025) and -$2.68 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.23
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.05
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.01
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.14
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.96
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.57
10 FibroBiologics 6.13 Mn -8.69 Mn - -0.66
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.66
Mar 31, 2026 -1.33
Dec 31, 2025 -1.45
Sep 30, 2025 -2.68
Jun 30, 2025 -2.41
Mar 31, 2025 -2.71
Dec 31, 2024 -1.89
Sep 30, 2024 -0.30
Jun 30, 2024 0.55
Mar 31, 2024 -5.43
Dec 31, 2023 -6.88
Sep 30, 2023 -1.55
Jun 30, 2023 -1.53
Mar 31, 2023 -3.53
API Access

FibroBiologics EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=FBLG&period=max&api_key=YOUR_API_KEY